Markets:

Overview

News

Currencies

International

Treasuries

INmune Bio Inc. - Common stock (NQ:INMB)

1.470 -0.100 (-6.37%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about INmune Bio Inc. - Common stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 26, 2025

Via Benzinga

Get insights into the top gainers and losers of Thursday's after-hours session. ↗

June 26, 2025

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗

April 22, 2025

Via Benzinga

What to Expect from INmune Bio's Earnings ↗

March 26, 2025

Via Benzinga

INmune Bio: Q4 Earnings Insights ↗

March 28, 2024

Via Benzinga

A Preview Of INmune Bio's Earnings ↗

March 27, 2024

Via Benzinga

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 27, 2025

Via Benzinga

Earnings Outlook For INmune Bio ↗

August 04, 2023

Via Benzinga

INmune Bio's Earnings Outlook ↗

May 02, 2023

Via Benzinga

INmune Bio Earnings Perspective: Return On Capital Employed ↗

March 08, 2023

Via Benzinga

Earnings Preview: INmune Bio ↗

March 01, 2023

Via Benzinga

C-Suite Buy of the Week: Executive Moves from Biotech to Banking ↗

January 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 20, 2024

Via Benzinga

INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

INMB stock results show that INmune Bio missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023 ↗

March 28, 2024

INMB stock results show that INmune Bio missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Why Is Elevai Labs (ELAB) Stock Up Today? ↗

January 16, 2024

Elevai Labs is soaring on an intriguing licensing agreement with INmune Bio, but the narrative presents a mixed bag for ELAB stock.

Via InvestorPlace

Why Elevai Labs Stock Is Trading Higher ↗

January 16, 2024

Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune...

Via Benzinga

INmune Bio's INKmune Shows Positive Efficacy In Multiple Cancer Cell Lines ↗

October 19, 2022

Via Benzinga

Earnings Scheduled For March 28, 2024 ↗

March 28, 2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

December 19, 2023

It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning!

Via InvestorPlace

Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning ↗

November 17, 2023

Biotech companies are edging closer to finding the answers behind Alzheimer's disease.

Via Investor's Business Daily

INmune Bio – Helping Your Own Cells Fight Cancer And Reverse Alzheimer's Disease ↗

June 13, 2023

David Moss, CEO of INmune Bio (NASDAQ: INMB) was recently a guest on Benzinga’s All-Access.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2023 ↗

June 01, 2023

Via Benzinga

The 7 Best Biotech Stocks for Personalized Medicine Investors ↗

April 25, 2023

Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics.

Via InvestorPlace

Dow Jumps 250 Points; US Jobless Claims Increase Last Week ↗

February 09, 2023

U.S. stocks traded higher this morning, with the Dow Jones jumping around 250 points on Thursday. The Dow traded up 0.75% to 34,204.99 while the NASDAQ rose 1.15% to 12,047.28. The S&P 500 also rose,...

Via Benzinga

Nasdaq Tumbles 150 Points; Crude Oil Up 1.5% ↗

February 08, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 150 points on Wednesday. The Dow traded down 0.27% to 34,063.42 while the NASDAQ fell 1.33% to 11,952.51. The...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 25, 2023

Via Benzinga

Recap: INmune Bio Q2 Earnings ↗

August 03, 2022

INmune Bio (NASDAQ:INMB) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings INmune Bio beat estimated...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

INmune Bio Inc. - Common stock (NQ:INMB)

Headline News about INmune Bio Inc. - Common stock

Starting at $3.75/week.

Subscribe Today